Financials
- Market Capitalization 1.53 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
—
Rapporto prezzo/fatturato
4.65
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2146 | BCAX Bicara Therapeutics Inc. - Common Stock | 24.83 USD | +0.40% | +2.22% | -7.63% | +71.95% | 1.64 B USD | ||
| 2152 | FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.06% | +0.50% | +162.32% | 1.63 B USD | ||
| 2179 | TYRA Tyra Biosciences, Inc. - Common Stock | 25.32 USD | -3.10% | -4.60% | -19.16% | +76.57% | 1.51 B USD | ||
| 2187 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.20 USD | -1.44% | +0.23% | +34.32% | +148.42% | 1.52 B USD |